title: [Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].
abstract: It is well known that prognosis of patients with hepatocellular carcinoma (HCC) depends not only cancer spread, but also on liver disease stage. The Japan Integrated Staging (JIS) scoring system, which combines TNM stage and Child-Pugh stage, is superior to CLIP Score in the discriminatory ability of the prognosis in 3,934 patients with HCC. Therefore, it is also useful in the comparison of the treatment results between treatment modalities or between institutions. It is thus recommended that the JIS score be used in the comparison of treatment results of patients with HCC.
authors.affiliation: Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan,
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Kudo
authors.forename: Hobyung
authors.initials: H
authors.lastname: Chung
authors.forename: Yukio
authors.initials: Y
authors.lastname: Osaki
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kasugai
authors.forename: Hiroko
authors.initials: H
authors.lastname: Oka
authors.forename: Toshihito
authors.initials: T
authors.lastname: Seki
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D015337:Multicenter Studies as Topic; D009367:Neoplasm Staging / Q000379:methods*; D011379:Prognosis; D015996:Survival Rate